▶ 調査レポート

カルシウムチャネル遮断薬の世界及び中国市場

• 英文タイトル:Global and China Calcium Channel Blocker Market Insights, Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。カルシウムチャネル遮断薬の世界及び中国市場 / Global and China Calcium Channel Blocker Market Insights, Forecast to 2027 / QY2108PAL8784資料のイメージです。• レポートコード:QY2108PAL8784
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、146ページ
• 納品方法:Eメール(納期:1日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおけるカルシウムチャネル遮断薬の市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、カルシウムチャネル遮断薬の種類別市場規模(ジヒドロピリジン、ジルチアゼム、ベラパミル、その他)、用途別市場規模(高血圧、冠状動脈疾患、不整脈、心筋症)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のカルシウムチャネル遮断薬市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるカルシウムチャネル遮断薬の種類別市場規模(2016年-2027年):ジヒドロピリジン、ジルチアゼム、ベラパミル、その他
・世界におけるカルシウムチャネル遮断薬の用途別市場規模(2016年-2027年):高血圧、冠状動脈疾患、不整脈、心筋症
・カルシウムチャネル遮断薬の中国市場分析
- カルシウムチャネル遮断薬の中国市場規模(2016年-2027年)
- 中国におけるカルシウムチャネル遮断薬の主要プレイヤー別市場シェア
- 中国におけるカルシウムチャネル遮断薬の種類別市場規模:ジヒドロピリジン、ジルチアゼム、ベラパミル、その他
- 中国におけるカルシウムチャネル遮断薬の用途別市場規模:高血圧、冠状動脈疾患、不整脈、心筋症
・カルシウムチャネル遮断薬の北米市場(2016年-2027年)
・カルシウムチャネル遮断薬のヨーロッパ市場(2016年-2027年)
・カルシウムチャネル遮断薬のアジア太平洋市場(2016年-2027年)
・カルシウムチャネル遮断薬の中南米市場(2016年-2027年)
・カルシウムチャネル遮断薬の中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Pfizer、Aventis、Searle、Bayer、AstraZeneca、Knoll Pharmaceuticals、Wyeth-Ayerst、AstraZeneca、Novartis、Sanofi
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.

Market Analysis and Insights: Global and China Calcium Channel Blocker Market
This report focuses on global and China Calcium Channel Blocker market.
In 2020, the global Calcium Channel Blocker market size was US$ 76 million and it is expected to reach US$ 84 million by the end of 2027, with a CAGR of 1.6% during 2021-2027. In China the Calcium Channel Blocker market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Calcium Channel Blocker Scope and Market Size
Calcium Channel Blocker market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Calcium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Calcium Channel Blocker market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Dihydropyridine
Diltiazem
Verapamil
Others

Segment by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi

レポート目次

1 Study Coverage
1.1 Calcium Channel Blocker Product Introduction
1.2 Market by Type
1.2.1 Global Calcium Channel Blocker Market Size Growth Rate by Type
1.2.2 Dihydropyridine
1.2.3 Diltiazem
1.2.4 Verapamil
1.2.5 Others
1.3 Market by Application
1.3.1 Global Calcium Channel Blocker Market Size Growth Rate by Application
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Cardiomyopathy
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Calcium Channel Blocker Market Size, Estimates and Forecasts
2.1.1 Global Calcium Channel Blocker Revenue 2016-2027
2.1.2 Global Calcium Channel Blocker Sales 2016-2027
2.2 Global Calcium Channel Blocker, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Calcium Channel Blocker Historical Market Size by Region (2016-2021)
2.3.1 Global Calcium Channel Blocker Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Calcium Channel Blocker Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Calcium Channel Blocker Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Calcium Channel Blocker Sales Forecast by Region (2022-2027)
2.4.2 Global Calcium Channel Blocker Revenue Forecast by Region (2022-2027)

3 Global Calcium Channel Blocker Competitor Landscape by Players
3.1 Global Top Calcium Channel Blocker Manufacturers by Sales
3.1.1 Global Calcium Channel Blocker Sales by Manufacturer (2016-2021)
3.1.2 Global Calcium Channel Blocker Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Calcium Channel Blocker Manufacturers by Revenue
3.2.1 Key Calcium Channel Blocker Manufacturers Covered: Ranking by Revenue
3.2.2 Global Calcium Channel Blocker Revenue by Manufacturers (2016-2021)
3.2.3 Global Calcium Channel Blocker Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Calcium Channel Blocker Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Calcium Channel Blocker Revenue in 2020
3.2.6 Global Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Calcium Channel Blocker Price by Manufacturers
3.4 Global Calcium Channel Blocker Manufacturing Base Distribution, Product Types
3.4.1 Calcium Channel Blocker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Calcium Channel Blocker Product Type
3.4.3 Date of International Manufacturers Enter into Calcium Channel Blocker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Calcium Channel Blocker Market Size by Type (2016-2021)
4.1.1 Global Calcium Channel Blocker Sales by Type (2016-2021)
4.1.2 Global Calcium Channel Blocker Revenue by Type (2016-2021)
4.1.3 Calcium Channel Blocker Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Calcium Channel Blocker Market Size Forecast by Type (2022-2027)
4.2.1 Global Calcium Channel Blocker Sales Forecast by Type (2022-2027)
4.2.2 Global Calcium Channel Blocker Revenue Forecast by Type (2022-2027)
4.2.3 Calcium Channel Blocker Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Calcium Channel Blocker Market Size by Application (2016-2021)
5.1.1 Global Calcium Channel Blocker Sales by Application (2016-2021)
5.1.2 Global Calcium Channel Blocker Revenue by Application (2016-2021)
5.1.3 Calcium Channel Blocker Price by Application (2016-2021)
5.2 Calcium Channel Blocker Market Size Forecast by Application (2022-2027)
5.2.1 Global Calcium Channel Blocker Sales Forecast by Application (2022-2027)
5.2.2 Global Calcium Channel Blocker Revenue Forecast by Application (2022-2027)
5.2.3 Global Calcium Channel Blocker Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Calcium Channel Blocker Market Size YoY Growth 2016-2027
6.1.1 China Calcium Channel Blocker Sales YoY Growth 2016-2027
6.1.2 China Calcium Channel Blocker Revenue YoY Growth 2016-2027
6.1.3 China Calcium Channel Blocker Market Share in Global Market 2016-2027
6.2 China Calcium Channel Blocker Market Size by Players (International and Local Players)
6.2.1 China Top Calcium Channel Blocker Players by Sales (2016-2021)
6.2.2 China Top Calcium Channel Blocker Players by Revenue (2016-2021)
6.3 China Calcium Channel Blocker Historic Market Review by Type (2016-2021)
6.3.1 China Calcium Channel Blocker Sales Market Share by Type (2016-2021)
6.3.2 China Calcium Channel Blocker Revenue Market Share by Type (2016-2021)
6.3.3 China Calcium Channel Blocker Price by Type (2016-2021)
6.4 China Calcium Channel Blocker Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Calcium Channel Blocker Sales Forecast by Type (2022-2027)
6.4.2 China Calcium Channel Blocker Revenue Forecast by Type (2022-2027)
6.4.3 China Calcium Channel Blocker Price Forecast by Type (2022-2027)
6.5 China Calcium Channel Blocker Historic Market Review by Application (2016-2021)
6.5.1 China Calcium Channel Blocker Sales Market Share by Application (2016-2021)
6.5.2 China Calcium Channel Blocker Revenue Market Share by Application (2016-2021)
6.5.3 China Calcium Channel Blocker Price by Application (2016-2021)
6.6 China Calcium Channel Blocker Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Calcium Channel Blocker Sales Forecast by Application (2022-2027)
6.6.2 China Calcium Channel Blocker Revenue Forecast by Application (2022-2027)
6.6.3 China Calcium Channel Blocker Price Forecast by Application (2022-2027)

7 North America
7.1 North America Calcium Channel Blocker Market Size YoY Growth 2016-2027
7.2 North America Calcium Channel Blocker Market Facts & Figures by Country
7.2.1 North America Calcium Channel Blocker Sales by Country (2016-2021)
7.2.2 North America Calcium Channel Blocker Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Calcium Channel Blocker Market Size YoY Growth 2016-2027
8.2 Asia Pacific Calcium Channel Blocker Market Facts & Figures by Region
8.2.1 Asia Pacific Calcium Channel Blocker Sales by Region (2016-2021)
8.2.2 Asia Pacific Calcium Channel Blocker Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Calcium Channel Blocker Market Size YoY Growth 2016-2027
9.2 Europe Calcium Channel Blocker Market Facts & Figures by Country
9.2.1 Europe Calcium Channel Blocker Sales by Country (2016-2021)
9.2.2 Europe Calcium Channel Blocker Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Calcium Channel Blocker Market Size YoY Growth 2016-2027
10.2 Latin America Calcium Channel Blocker Market Facts & Figures by Country
10.2.1 Latin America Calcium Channel Blocker Sales by Country (2016-2021)
10.2.2 Latin America Calcium Channel Blocker Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Calcium Channel Blocker Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Calcium Channel Blocker Market Facts & Figures by Country
11.2.1 Middle East and Africa Calcium Channel Blocker Sales by Country (2016-2021)
11.2.2 Middle East and Africa Calcium Channel Blocker Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Calcium Channel Blocker Products Offered
12.1.5 Pfizer Recent Development
12.2 Aventis
12.2.1 Aventis Corporation Information
12.2.2 Aventis Description and Business Overview
12.2.3 Aventis Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Aventis Calcium Channel Blocker Products Offered
12.2.5 Aventis Recent Development
12.3 Searle
12.3.1 Searle Corporation Information
12.3.2 Searle Description and Business Overview
12.3.3 Searle Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Searle Calcium Channel Blocker Products Offered
12.3.5 Searle Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Description and Business Overview
12.4.3 Bayer Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Calcium Channel Blocker Products Offered
12.4.5 Bayer Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Description and Business Overview
12.5.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Calcium Channel Blocker Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Knoll Pharmaceuticals
12.6.1 Knoll Pharmaceuticals Corporation Information
12.6.2 Knoll Pharmaceuticals Description and Business Overview
12.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Products Offered
12.6.5 Knoll Pharmaceuticals Recent Development
12.7 Wyeth-Ayerst
12.7.1 Wyeth-Ayerst Corporation Information
12.7.2 Wyeth-Ayerst Description and Business Overview
12.7.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Wyeth-Ayerst Calcium Channel Blocker Products Offered
12.7.5 Wyeth-Ayerst Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AstraZeneca Calcium Channel Blocker Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Novartis
12.9.1 Novartis Corporation Information
12.9.2 Novartis Description and Business Overview
12.9.3 Novartis Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Novartis Calcium Channel Blocker Products Offered
12.9.5 Novartis Recent Development
12.10 Sanofi
12.10.1 Sanofi Corporation Information
12.10.2 Sanofi Description and Business Overview
12.10.3 Sanofi Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sanofi Calcium Channel Blocker Products Offered
12.10.5 Sanofi Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Calcium Channel Blocker Products Offered
12.11.5 Pfizer Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Calcium Channel Blocker Industry Trends
13.2 Calcium Channel Blocker Market Drivers
13.3 Calcium Channel Blocker Market Challenges
13.4 Calcium Channel Blocker Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Calcium Channel Blocker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Calcium Channel Blocker Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dihydropyridine
Table 3. Major Manufacturers of Diltiazem
Table 4. Major Manufacturers of Verapamil
Table 5. Major Manufacturers of Others
Table 6. Global Calcium Channel Blocker Market Size Growth Rate by Application (2021-2027) & (Kg)
Table 7. Global Calcium Channel Blocker Market Size by Region (Kg) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Calcium Channel Blocker Sales by Regions (2016-2021) & (Kg)
Table 9. Global Calcium Channel Blocker Sales Market Share by Regions (2016-2021)
Table 10. Global Calcium Channel Blocker Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Calcium Channel Blocker Sales Forecast by Region (2022-2027) & (Kg)
Table 12. Global Calcium Channel Blocker Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Calcium Channel Blocker Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Calcium Channel Blocker Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Calcium Channel Blocker Sales by Manufacturers (2016-2021) (Kg)
Table 16. Global Calcium Channel Blocker Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Calcium Channel Blocker Manufacturers by Revenue (US$ Million) in 2020
Table 18. Calcium Channel Blocker Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Calcium Channel Blocker Revenue Share by Manufacturers (2016-2021)
Table 20. Global Calcium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Calcium Channel Blocker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Channel Blocker as of 2020)
Table 22. Key Manufacturers Calcium Channel Blocker Price (2016-2021) (USD/g)
Table 23. Calcium Channel Blocker Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Calcium Channel Blocker Product Type
Table 25. Date of International Manufacturers Enter into Calcium Channel Blocker Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Calcium Channel Blocker Sales by Type (2016-2021) (Kg)
Table 28. Global Calcium Channel Blocker Sales Share by Type (2016-2021)
Table 29. Global Calcium Channel Blocker Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Calcium Channel Blocker Revenue Share by Type (2016-2021)
Table 31. Calcium Channel Blocker Average Selling Price (ASP) by Type (2016-2021) & (USD/g)
Table 32. Global Calcium Channel Blocker Sales Forecast by Type (2022-2027) & (Kg)
Table 33. Global Calcium Channel Blocker Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Calcium Channel Blocker Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Calcium Channel Blocker Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Calcium Channel Blocker Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/g)
Table 37. Global Calcium Channel Blocker Sales by Application (2016-2021) (Kg)
Table 38. Global Calcium Channel Blocker Sales Share by Application (2016-2021)
Table 39. Global Calcium Channel Blocker Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Calcium Channel Blocker Revenue Share by Application (2016-2021)
Table 41. Calcium Channel Blocker Average Selling Price (ASP) by Application (2016-2021) & (USD/g)
Table 42. Global Calcium Channel Blocker Sales Forecast by Application (2022-2027) & (Kg)
Table 43. Global Calcium Channel Blocker Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Calcium Channel Blocker Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Calcium Channel Blocker Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Calcium Channel Blocker Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/g)
Table 47. China Calcium Channel Blocker Sales (Kg) of Key Companies (2016-2021)
Table 48. China Calcium Channel Blocker Sales Share by Company (2016-2021)
Table 49. China Calcium Channel Blocker Revenue (US$ Million) by Company (2016-2021)
Table 50. China Calcium Channel Blocker Revenue Share by Company (2016-2021)
Table 51. China Calcium Channel Blocker Sales (Kg) by Type (2016-2021)
Table 52. China Calcium Channel Blocker Sales Share by Type (2016-2021)
Table 53. China Calcium Channel Blocker Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Calcium Channel Blocker Price (USD/g) by Type (2016-2021)
Table 55. China Calcium Channel Blocker Sales (Kg) by Type (2022-2027)
Table 56. China Calcium Channel Blocker Sales Share by Type (2022-2027)
Table 57. China Calcium Channel Blocker Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Calcium Channel Blocker Revenue Share by Type (2022-2027)
Table 59. China Calcium Channel Blocker Price (USD/g) by Type (2022-2027)
Table 60. China Calcium Channel Blocker Sales (Kg) by Application (2016-2021)
Table 61. China Calcium Channel Blocker Sales Share by Application (2016-2021)
Table 62. China Calcium Channel Blocker Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Calcium Channel Blocker Price (USD/g) by Application (2016-2021)
Table 64. China Calcium Channel Blocker Sales (Kg) by Application (2022-2027)
Table 65. China Calcium Channel Blocker Sales Share by Application (2022-2027)
Table 66. China Calcium Channel Blocker Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Calcium Channel Blocker Revenue Share by Application (2022-2027)
Table 68. China Calcium Channel Blocker Price (USD/g) by Application (2022-2027)
Table 69. North America Calcium Channel Blocker Sales by Country (2016-2021) & (Kg)
Table 70. North America Calcium Channel Blocker Sales Market Share by Country (2016-2021)
Table 71. North America Calcium Channel Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Calcium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Calcium Channel Blocker Sales by Region (2016-2021) & (Kg)
Table 74. Asia Pacific Calcium Channel Blocker Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Calcium Channel Blocker Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Calcium Channel Blocker Revenue Market Share by Region (2016-2021)
Table 77. Europe Calcium Channel Blocker Sales by Country (2016-2021) & (Kg)
Table 78. Europe Calcium Channel Blocker Sales Market Share by Country (2016-2021)
Table 79. Europe Calcium Channel Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Calcium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 81. Latin America Calcium Channel Blocker Sales by Country (2016-2021) & (Kg)
Table 82. Latin America Calcium Channel Blocker Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Calcium Channel Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Calcium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Calcium Channel Blocker Sales by Country (2016-2021) & (Kg)
Table 86. Middle East and Africa Calcium Channel Blocker Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Calcium Channel Blocker Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Calcium Channel Blocker Revenue Market Share by Country (2016-2021)
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 92. Pfizer Calcium Channel Blocker Product
Table 93. Pfizer Recent Development
Table 94. Aventis Corporation Information
Table 95. Aventis Description and Business Overview
Table 96. Aventis Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 97. Aventis Product
Table 98. Aventis Recent Development
Table 99. Searle Corporation Information
Table 100. Searle Description and Business Overview
Table 101. Searle Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 102. Searle Product
Table 103. Searle Recent Development
Table 104. Bayer Corporation Information
Table 105. Bayer Description and Business Overview
Table 106. Bayer Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 107. Bayer Product
Table 108. Bayer Recent Development
Table 109. AstraZeneca Corporation Information
Table 110. AstraZeneca Description and Business Overview
Table 111. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 112. AstraZeneca Product
Table 113. AstraZeneca Recent Development
Table 114. Knoll Pharmaceuticals Corporation Information
Table 115. Knoll Pharmaceuticals Description and Business Overview
Table 116. Knoll Pharmaceuticals Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 117. Knoll Pharmaceuticals Product
Table 118. Knoll Pharmaceuticals Recent Development
Table 119. Wyeth-Ayerst Corporation Information
Table 120. Wyeth-Ayerst Description and Business Overview
Table 121. Wyeth-Ayerst Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 122. Wyeth-Ayerst Product
Table 123. Wyeth-Ayerst Recent Development
Table 124. AstraZeneca Corporation Information
Table 125. AstraZeneca Description and Business Overview
Table 126. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 127. AstraZeneca Product
Table 128. AstraZeneca Recent Development
Table 129. Novartis Corporation Information
Table 130. Novartis Description and Business Overview
Table 131. Novartis Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 132. Novartis Product
Table 133. Novartis Recent Development
Table 134. Sanofi Corporation Information
Table 135. Sanofi Description and Business Overview
Table 136. Sanofi Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021)
Table 137. Sanofi Product
Table 138. Sanofi Recent Development
Table 139. Calcium Channel Blocker Market Trends
Table 140. Calcium Channel Blocker Market Drivers
Table 141. Calcium Channel Blocker Market Challenges
Table 142. Calcium Channel Blocker Market Restraints
Table 143. Calcium Channel Blocker Customers List
Table 144. Calcium Channel Blocker Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcium Channel Blocker Product Picture
Figure 2. Global Calcium Channel Blocker Sales Market Share by Type in 2020 & 2027
Figure 3. Dihydropyridine Product Picture
Figure 4. Diltiazem Product Picture
Figure 5. Verapamil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Calcium Channel Blocker Sales Market Share by Application in 2020 & 2027
Figure 8. Hypertension
Figure 9. Coronary Artery Disease
Figure 10. Arrhythmia
Figure 11. Cardiomyopathy
Figure 12. Calcium Channel Blocker Report Years Considered
Figure 13. Global Calcium Channel Blocker Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Calcium Channel Blocker Market Size 2016-2027 (US$ Million)
Figure 15. Global Calcium Channel Blocker Sales 2016-2027 (Kg)
Figure 16. Global Calcium Channel Blocker Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Calcium Channel Blocker Sales Market Share by Region (2016-2021)
Figure 18. Global Calcium Channel Blocker Sales Market Share by Region in 2020
Figure 19. Global Calcium Channel Blocker Revenue Market Share by Region (2016-2021)
Figure 20. Global Calcium Channel Blocker Revenue Market Share by Region in 2020
Figure 21. Global Calcium Channel Blocker Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Calcium Channel Blocker Revenue in 2020
Figure 23. Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Calcium Channel Blocker Sales Market Share by Type (2016-2021)
Figure 25. Global Calcium Channel Blocker Sales Market Share by Type in 2020
Figure 26. Global Calcium Channel Blocker Revenue Market Share by Type (2016-2021)
Figure 27. Global Calcium Channel Blocker Revenue Market Share by Type in 2020
Figure 28. Global Calcium Channel Blocker Sales Market Share by Application (2016-2021)
Figure 29. Global Calcium Channel Blocker Sales Market Share by Application in 2020
Figure 30. Global Calcium Channel Blocker Revenue Market Share by Application (2016-2021)
Figure 31. Global Calcium Channel Blocker Revenue Market Share by Application in 2020
Figure 32. China Calcium Channel Blocker Sales Growth Rate 2016-2027 (Kg)
Figure 33. China Calcium Channel Blocker Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Calcium Channel Blocker Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Calcium Channel Blocker Players Market Share by Revenue in Calcium Channel Blocker in 2020
Figure 36. China Calcium Channel Blocker Revenue Share by Type (2016-2021)
Figure 37. China Calcium Channel Blocker Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Calcium Channel Blocker Revenue Share by Application (2016-2021)
Figure 39. China Calcium Channel Blocker Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Calcium Channel Blocker Sales Growth Rate 2016-2021 (Kg)
Figure 41. North America Calcium Channel Blocker Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Calcium Channel Blocker Sales Market Share by Country in 2020
Figure 43. North America Calcium Channel Blocker Revenue Market Share by Country in 2020
Figure 44. U.S. Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 45. U.S. Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 47. Canada Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Calcium Channel Blocker Sales Growth Rate 2016-2021 (Kg)
Figure 49. Europe Calcium Channel Blocker Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Calcium Channel Blocker Sales Market Share by Country in 2020
Figure 51. Europe Calcium Channel Blocker Revenue Market Share by Country in 2020
Figure 52. Germany Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 53. Germany Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 55. France Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 57. U.K. Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 59. Italy Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 61. Russia Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Calcium Channel Blocker Sales Growth Rate 2016-2021 (Kg)
Figure 63. Asia Pacific Calcium Channel Blocker Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Calcium Channel Blocker Sales Market Share by Region in 2020
Figure 65. Asia Pacific Calcium Channel Blocker Revenue Market Share by Region in 2020
Figure 66. China Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 67. China Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 69. Japan Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 71. South Korea Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 73. India Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 75. Australia Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. China Taiwan Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 77. China Taiwan Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 79. Indonesia Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 81. Thailand Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 83. Malaysia Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Calcium Channel Blocker Sales Growth Rate 2016-2021 (Kg)
Figure 85. Latin America Calcium Channel Blocker Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Calcium Channel Blocker Sales Market Share by Country in 2020
Figure 87. Latin America Calcium Channel Blocker Revenue Market Share by Country in 2020
Figure 88. Mexico Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 89. Mexico Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 91. Brazil Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 93. Argentina Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Calcium Channel Blocker Sales Growth Rate 2016-2021 (Kg)
Figure 95. Middle East and Africa Calcium Channel Blocker Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Calcium Channel Blocker Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Calcium Channel Blocker Revenue Market Share by Country in 2020
Figure 98. Turkey Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 99. Turkey Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 101. Saudi Arabia Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Calcium Channel Blocker Sales Growth Rate (2016-2021) (Kg)
Figure 103. UAE Calcium Channel Blocker Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Calcium Channel Blocker Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed